<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 16.5: The Refractory Gut: SIBO, IMO, and the Migrating Motor Complex</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - TEAL theme for Advanced GI */
        .module-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0d9488;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0d9488;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Objectives Box */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0d9488;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111827;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Stat Highlight */
        .stat-highlight {
            background: #f0fdfa;
            padding: 4px 8px;
            border-radius: 4px;
            color: #0d9488;
            font-weight: 700;
            border: 1px solid #99f6e4;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #14b8a6;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 16px;
            font-weight: 600;
            color: #374151;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #0d9488;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdfa;
            border-radius: 8px;
            border-left: 4px solid #14b8a6;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #e5e7eb;
            font-size: 14px;
            color: #6b7280;
        }

        .references-box h4 {
            color: #374151;
            margin-top: 0;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 50px;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 16: Advanced Case Studies</p>
            <h1 class="lesson-title">L5: The Refractory Gut: SIBO, IMO, and the Migrating Motor Complex</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Advanced Level</span>
                <span class="meta-item">üß™ Clinical Focus</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#pathophysiology"><span class="section-num">1</span>The MMC & The Housekeeper Wave</a></li>
                <li><a href="#autoimmunity"><span class="section-num">2</span>The Anti-Vinculin Connection</a></li>
                <li><a href="#trio-smart"><span class="section-num">3</span>Trio-Smart & IMO Dynamics</a></li>
                <li><a href="#blended-treatment"><span class="section-num">4</span>Blended Antimicrobial Protocols</a></li>
                <li><a href="#prokinetics"><span class="section-num">5</span>The Prokinetic Evolution</a></li>
                <li><a href="#case-studies"><span class="section-num">6</span>Clinical Case Analysis</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the physiological mechanism of the <span class="highlight">Migrating Motor Complex (MMC)</span> and its role in preventing bacterial translocation.</li>
                <li>Identify the autoimmune triggers (Anti-CdtB/Anti-Vinculin) following acute gastroenteritis that lead to refractory SIBO.</li>
                <li>Differentiate between Hydrogen SIBO and <span class="highlight">Intestinal Methanogen Overgrowth (IMO)</span> using Trio-smart breath data.</li>
                <li>Design a "Blended Approach" protocol utilizing both pharmaceutical and botanical antimicrobials tailored to gas profiles.</li>
                <li>Implement an "Evolve & Optimize" strategy using prokinetics and the Biphasic Diet to prevent recurrence.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Challenge of the "Relapsing" Patient</h3>
            <p>In clinical practice, few conditions are as frustrating for both practitioner and patient as Small Intestinal Bacterial Overgrowth (SIBO). Despite successful antimicrobial rounds, <span class="stat-highlight">recurrence rates can reach 44% within 9 months</span>. To achieve long-term resolution, we must move beyond "killing the bugs" and apply the <strong>B.R.I.D.G.E. Method‚Ñ¢</strong> to address the underlying failure of the gut's "housekeeping" system: the Migrating Motor Complex.</p>
        </div>

        <h2 id="pathophysiology">1. The Migrating Motor Complex (MMC): The Housekeeper Wave</h2>
        <p>The MMC is a distinct electromechanical pattern of GI motility that occurs primarily during fasting. Unlike peristalsis (which moves food), the MMC acts as a <span class="highlight">sweeping mechanism</span>, pushing undigested food, debris, and‚Äîcritically‚Äîbacteria from the small intestine into the colon.</p>
        
        <p>A 2021 study involving 142 patients found that <span class="stat-highlight">87% of SIBO patients</span> exhibited significantly reduced Phase III MMC activity. Without this "housekeeper wave," bacteria from the large intestine can migrate retrograde into the nutrient-rich small intestine, leading to fermentation, gas production, and malabsorption.</p>

        <h2 id="autoimmunity">2. Root Cause Analysis: The Post-Infectious Autoimmune Trigger</h2>
        <p>Using the <strong>R (Root Cause)</strong> of the B.R.I.D.G.E. framework, we must investigate <em>why</em> the MMC failed. Often, the trigger is a single episode of food poisoning (acute gastroenteritis).</p>
        
        <p>Bacteria such as <em>Campylobacter, Salmonella,</em> and <em>E. coli</em> release <span class="highlight">Cytolethal Distending Toxin B (CdtB)</span>. Through a process of <strong>molecular mimicry</strong>, the body produces antibodies against CdtB that cross-react with <strong>Vinculin</strong>, a protein critical for the health of the Interstitial Cells of Cajal (the "pacemakers" of the gut). This autoimmune attack paralyzes the MMC, creating a permanent structural vulnerability to bacterial overgrowth.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Biomarker</th>
                        <th>Pathophysiological Significance</th>
                        <th>Clinical Implication</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Anti-CdtB</strong></td>
                        <td>Indicates previous exposure to food poisoning toxins.</td>
                        <td>Confirms SIBO is post-infectious (PI-IBS).</td>
                    </tr>
                    <tr>
                        <td><strong>Anti-Vinculin</strong></td>
                        <td>Indicates autoimmune damage to gut nerves/pacemakers.</td>
                        <td>Predicts high recurrence risk; necessitates long-term prokinetics.</td>
                    </tr>
                    <tr>
                        <td><strong>Hydrogen (H2)</strong></td>
                        <td>Produced by bacterial fermentation of carbohydrates.</td>
                        <td>Associated with diarrhea-dominant symptoms (SIBO).</td>
                    </tr>
                    <tr>
                        <td><strong>Methane (CH4)</strong></td>
                        <td>Produced by <em>Methanobrevibacter smithii</em> (Archaea).</td>
                        <td>Associated with constipation and IMO (can be colonic).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="trio-smart">3. Data-Driven Decisions: Hydrogen, Methane, and Hydrogen Sulfide</h2>
        <p>The <strong>D (Data-Driven Decisions)</strong> pillar requires precise testing. Traditional breath tests only measured Hydrogen and Methane. The <span class="highlight">Trio-smart test</span> now includes Hydrogen Sulfide (H2S), which is often the missing piece in "flat-line" breath tests where the patient is symptomatic but results appear negative.</p>
        
        <p>Hydrogen Sulfide overgrowth is frequently associated with visceral hypersensitivity and "rotten egg" smelling gas. Understanding the gas profile is essential for the <strong>B (Blend)</strong> phase of treatment, as methanogens (Archaea) are structurally different from bacteria and require different antimicrobial agents.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study 1: The Relapsing Executive</p>
                    <p class="subtitle">Post-Infectious SIBO with Autoimmune Markers</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James, 42</h4>
                        <p>Symptoms: Chronic bloating, 4-5 loose stools/day, brain fog. Symptoms began after a trip to Mexico 3 years ago.</p>
                    </div>
                </div>
                <p><strong>Initial Findings:</strong> James had completed three rounds of Rifaximin, each providing relief for only 4-6 weeks before symptoms returned. Trio-smart showed Hydrogen peaks at 48 ppm at the 90-minute mark.</p>
                <p><strong>Root Cause Analysis:</strong> IBS-Smart blood test revealed <strong>Anti-CdtB: 3.8 (High)</strong> and <strong>Anti-Vinculin: 2.1 (High)</strong>. This confirmed that James's MMC was structurally impaired by autoimmunity.</p>
                <p><strong>Intervention (The B.R.I.D.G.E. Method‚Ñ¢):</strong>
                    <ul>
                        <li><strong>Blend:</strong> Rifaximin (550mg TID) combined with partially hydrolyzed guar gum (PHGG) to "wake up" the bacteria.</li>
                        <li><strong>Individualize:</strong> Low-FODMAP Diet for symptom control during treatment.</li>
                        <li><strong>Evolve:</strong> Immediate initiation of Prucalopride (0.5mg) at night post-treatment to force MMC activity.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> James remained symptom-free at the 12-month follow-up, provided he maintained the prokinetic and 4-hour meal spacing.</p>
            </div>
        </div>

        <h2 id="blended-treatment">4. Blended Treatment: Pharmacology meets Pharmacognosy</h2>
        <p>When treating IMO (Methane), Rifaximin alone has a success rate of only <span class="stat-highlight">~30%</span>. However, when <strong>Blended</strong> with Neomycin or Allicin (from garlic), success rates jump to <span class="stat-highlight">~85%</span>. </p>

        <h3>Botanical Antimicrobial Synergies</h3>
        <p>For patients who prefer a natural route or have failed antibiotics, a 2014 study by Mullin et al. demonstrated that herbal therapy (Oregano, Berberine, Wormwood) was <span class="highlight">equally effective as Rifaximin</span> in resolving SIBO. In the B.R.I.D.G.E. framework, we often use botanicals for the "second hit" or for maintenance.</p>

        <div class="principle-card">
            <div class="principle-title">The "Methane Protocol" (IMO Focus)</div>
            <div class="principle-text">
                Because <em>M. smithii</em> are Archaea, they are resistant to many standard antibiotics. A successful protocol usually requires:
                <ul>
                    <li><strong>Rifaximin + Neomycin:</strong> The gold standard pharmaceutical approach.</li>
                    <li><strong>Allicin (High Dose):</strong> 1350mg‚Äì2700mg daily. Allicin inhibits the enzyme needed for methane production.</li>
                    <li><strong>Oregano Oil (Emulsified):</strong> Acts as a broad-spectrum biofilm disruptor.</li>
                </ul>
            </div>
        </div>

        <h2 id="prokinetics">5. Evolve & Optimize: Life After Antimicrobials</h2>
        <p>The most common mistake in SIBO management is stopping after the kill phase. To <strong>Evolve & Optimize</strong>, we must address the "stagnant pond" environment.</p>

        <h3>I. Prokinetics (The Nightly Reset)</h3>
        <p>Prokinetics should be taken at bedtime, at least 4 hours after the last meal. This ensures the MMC is active during the long overnight fast.
            <ul>
                <li><strong>Pharmaceutical:</strong> Prucalopride (Motegrity) or Low-Dose Erythromycin.</li>
                <li><strong>Natural:</strong> Ginger root (1000mg) combined with 5-HTP or Artichoke extract (MotilPro/SIBO-MMC).</li>
            </ul>
        </p>

        <h3>II. Meal Spacing (The 4-Hour Rule)</h3>
        <p>The MMC is inhibited by the hormone <strong>Gastrin</strong>, which is released whenever we eat. Snacking effectively "turns off" the housekeeper wave. <strong>Guiding the Journey</strong> involves educating the patient on the necessity of a 4-5 hour gap between meals and a 12-hour overnight fast.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study 2: The Constipated "Healthy Eater"</p>
                    <p class="subtitle">IMO and Colonic Methane Dynamics</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">SL</div>
                    <div class="patient-info">
                        <h4>Sarah, 29</h4>
                        <p>Symptoms: Severe constipation (1 BM every 4 days), "pregnant-looking" bloating, gas that doesn't smell.</p>
                    </div>
                </div>
                <p><strong>Data:</strong> Trio-smart showed a baseline Methane of 18 ppm, rising to 42 ppm. This is diagnostic of IMO (Intestinal Methanogen Overgrowth).</p>
                <p><strong>Intervention:</strong> Sarah had a history of high-fiber intake ("healthy eating") which was fueling the methanogens. 
                    <ul>
                        <li><strong>Blend:</strong> Allicin (Allimed) 450mg TID + Neem 500mg TID for 4 weeks.</li>
                        <li><strong>Individualize:</strong> Transition to a <strong>Biphasic Diet</strong> (Phase 1: Restricted) to starve the methanogens of their hydrogen fuel source.</li>
                        <li><strong>Optimize:</strong> Magnesium Citrate and Triphala were used to ensure daily motility while the MMC was being rehabilitated.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> Methane dropped to 4 ppm. Bloating reduced by 80%. Sarah now manages symptoms with a "Low-Ferm" (Low Fermentation) diet rather than strict Low-FODMAP.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning on the refractory gut.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A patient presents with a "flat-line" breath test (0-2 ppm for H2 and CH4) but has severe bloating and visceral pain. What gas type should you suspect and what test is required?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Suspect <strong>Hydrogen Sulfide (H2S)</strong>. Standard breath tests only measure H2 and CH4; a <strong>Trio-smart</strong> test is required to measure H2S levels. H2S-producing bacteria compete for hydrogen, often making other gas levels appear lower than they are.
                </div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why is it clinically significant to test for Anti-Vinculin antibodies in a SIBO patient?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    High Anti-Vinculin indicates an <strong>autoimmune attack</strong> on the gut's pacemakers (Interstitial Cells of Cajal). This means the underlying motility defect (MMC failure) is likely permanent or long-term, signaling that the patient will require indefinite prokinetic support and strict meal spacing to prevent recurrence.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>The MMC is the Key:</strong> SIBO is rarely a primary disease; it is usually a symptom of a failed Migrating Motor Complex.</li>
                <li><strong>Autoimmune PI-IBS:</strong> Post-infectious SIBO is driven by molecular mimicry between CdtB toxins and the human protein Vinculin.</li>
                <li><strong>Methane is Different:</strong> IMO involves Archaea, not just bacteria, requiring Allicin or Neomycin alongside Rifaximin for successful eradication.</li>
                <li><strong>Meal Spacing is Therapeutic:</strong> Every time a patient snacks, they inhibit the MMC. Fasting intervals are as important as the antimicrobial agents.</li>
                <li><strong>Prokinetics are Non-Negotiable:</strong> In refractory cases, prokinetics must be started immediately following treatment to maintain the "sweeping" action of the small intestine.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Pimentel M, et al. (2020). "The Trio-Smart Breath Test for SIBO, IMO, and Hydrogen Sulfide." <i>American Journal of Gastroenterology.</i></li>
                <li>Rezaie A, et al. (2017). "Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus." <i>American Journal of Gastroenterology.</i></li>
                <li>Takakura W, et al. (2021). "The Migrating Motor Complex and Small Intestinal Bacterial Overgrowth." <i>Digestive Diseases and Sciences.</i></li>
                <li>Chedid V, et al. (2014). "Herbal Therapy is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth." <i>Global Advances in Health and Medicine.</i></li>
                <li>Pimentel M, et al. (2015). "Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome." <i>PLoS ONE.</i></li>
                <li>Ghoshal UC, et al. (2017). "Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional and Organic Gastrointestinal Diseases." <i>Gut and Liver.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. | Confidential Practitioner Training Material</p>
        </footer>
    </div>
</body>

</html>